Close Menu

More articles about Neurological & Psychological Disorders

The $3 million Stem Cell Commercialization Facility will open in June within 2,508 square feet of TechOne, the 100,000-square-foot first building of up to three that are planned to comprise the tech park, called TechTown.

Patent Watch: Feb 20, 2009

Premium

US Department of Veterans Affairs, Meso Scale Technologies, and Acadia Pharmaceuticals Awarded US Patents

IP Update: Feb 19, 2009

Premium

USPTO Publishes Six RNAi-Related Patent Applications

NHLBI plans to launch next month the prospectively designed, randomized-controlled study, called Clarification of Optimal Anticoagulation through Genetics trial, which will follow 1,200 patients to see if PGx-guided dosing is clinically useful.

New Products: Feb 6, 2009

Premium

Aruna Biomedical

Funding from the National Institutes of Health for all proteomics-related research shrank by almost 3 percent in fiscal 2008, according to an analysis of NIH data by ProteoMonitor.

Industry Briefs: Feb 5, 2009

Premium

Thermo Fisher Scientific, Agilent, NHLBI, Journal of Proteome Research, Roche, Fluorotechnics, and more.

Snippets: Feb 4, 2009

Premium

National Institutes of Health, Genomic Health, Decode Genetics, Myriad Genetics, Exact Sciences, and more …

Myriad attributed a 58 percent jump in molecular diagnostics revenues to an expansion of its sales force and an ongoing DTC campaign.

The exclusive pact gives Transgenomic rights to a diagnostic test for likelihood of neurodegenerative diseases.

Pages

Rady Children's Institute for Genomic Medicine and Deloitte are looking into the use of drones to transport samples for testing. 

Direct-to-consumer genetic testing firm 23andMe is laying off about 100 people.

Researchers from Northwestern University examined dust for antibiotic-resistance genes, New Scientist reports. 

In Science this week: researchers present a computational method for predicting cellular differentiation state from single-cell RNA sequencing data, and more.